Patents by Inventor Colin B. Reese

Colin B. Reese has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5625046
    Abstract: 1-N-substituted-4-alkoxy-piperidin-4-yl group is disclosed as a protecting reagent for the 2'-hydroxyl of oligo- or poly-ribonuleotides. This protecting group is applicable to the protection of the 2'-hydroxyl group during oligo- or poly-ribonucleotide synthesis. Nucleosides and nucleotides with the 2'-hydroxyl protected with 1-N-substituted-4-alkoxy-piperidin-4-yl group are also described.
    Type: Grant
    Filed: September 14, 1988
    Date of Patent: April 29, 1997
    Assignee: King's College London
    Inventor: Colin B. Reese
  • Patent number: 5436331
    Abstract: A process for protecting the 2'-hydroxyl of a nucleoside, which can then be used in the chemical synthesis of polyribonucleotides, comprising the reacting of a protected nucleoside of formula I ##STR1## wherein B is a nucleoside heterocyclic base and R' is a hydroxyl-protecting group,with 1-N-aryl-4-alkoxy-1,2,5,6-tetrahydropiperidine of formula II ##STR2## wherein Ar is an aryl group possessing an electron-withdrawing substituent which renders said protecting group acid labile and R is C.sub.1 -C.sub.
    Type: Grant
    Filed: March 29, 1993
    Date of Patent: July 25, 1995
    Assignee: Kings College London
    Inventor: Colin B. Reese
  • Patent number: 4937329
    Abstract: A process for the production of a 5-substituted derivative of a 2,3'-anhydro-2'-deoxyuridine preferably corresponding to the following general formula: ##STR1## wherein R.sup.1 represents H, alkyl, aryl, halogeno or CF.sub.3 ; characterized in that it comprises heating a 5-substituted derivative of a 2'-deoxyuridine preferably corresponding to the following general formula: ##STR2## wherein R.sup.1 is as defined above; in the presence of a sulphite transfer reagent and preferably a solvent is disclosed.This process improves the production of valuable intermediates and hence facilitates and reduces the cost of production of pharmacologically-interesting compounds.
    Type: Grant
    Filed: November 8, 1988
    Date of Patent: June 26, 1990
    Assignee: Efamol Holdings P.L.C.
    Inventor: Colin B. Reese